Pfizer (PFE) Treasury Shares (2009 - 2026)

Pfizer (PFE) has 18 years of Treasury Shares data on file, last reported at $115.2 billion in Q1 2026.

• Quarterly Treasury Shares changed 0.16% year-over-year to $115.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $115.2 billion (changed 0.16% YoY) and the FY2025 annual result came in at $115.0 billion, changed 0.22% from the prior year.
• Treasury Shares was little changed at $115.2 billion in Q1 2026 per PFE's latest filing, from $115.0 billion in the prior quarter.
• Across five years, Treasury Shares topped out at $3.9 billion in Q1 2026 and bottomed at $39.0 million in Q2 2022.
• The 5-year median for Treasury Shares is $3.9 billion (2024), against an average of $3.7 billion.
• The widest annual swing landed in 2022, when Treasury Shares climbed 2.34%; it then advanced 0.16% in 2026.
• Tracing PFE's Treasury Shares over 5 years: stood at $114.0 billion in 2022, then increased by 0.45% to $114.5 billion in 2023, then increased by 0.24% to $114.8 billion in 2024, then advanced by 0.22% to $115.0 billion in 2025, then gained by 0.15% to $115.2 billion in 2026.
• Per Business Quant, the three latest PFE Treasury Shares figures stand at $115.2 billion (Q1 2026), $115.0 billion (Q4 2025), and $115.0 billion (Q3 2025).

Peer Comparison